Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRNA

Moderna Inc

155.90

Aug 19 • 2:49 PM ET +92.94 (147.61%)

Healthcare Biotechnology USA Large NASD

Today, 2:00 PMModerna, Merck Phase 3 trial of mRNA melanoma therapy intismeran plus Keytruda meets primary and key secondary endpoints

Peers: BNTX ALNY INCY REGN ARGX BMRN VRTX BIIB AMGN GILD

| Held by: VTI VOO VB IVV VBR SPY RSP IBB XLV CGGR

Scroll to Statements

Index	S&P 500
Market Cap	62.24B
Enterprise Value	58.39B
Income	-3.15B
Sales	2.23B
Book/sh	16.94
Cash/sh	12.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4700
IPO	Dec 07, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	27.93
P/B	9.20
P/C	12.11
P/FCF	-
EV/EBITDA	-
EV/Sales	26.21
Quick Ratio	2.18
Current Ratio	2.29
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-7.98
EPS next Y	-4.90
EPS next Q	-1.16
EPS this Y	-17.04%
EPS next Y	42.36%
EPS next 5Y	27.48%
EPS past 3/5Y	- -29.93%
Sales past 3/5Y	-53.32% 19.33%
EPS Y/Y TTM	-6.22%
Sales Y/Y TTM	-27.62%
EPS Q/Q	7.60%
Sales Q/Q	2.11%
Earnings	Jul 31 BMO
EPS/Sales Surpr.	3.06% 40.87%

Insider Own	8.51%
Insider Trans	-2.45%
Inst Own	78.82%
Inst Trans	-2.19%
ROA	-27.43%
ROE	-39.00%
ROIC	-39.41%
Gross Margin	12.57%
Oper. Margin	-149.01%
Profit Margin	-141.43%
SMA20	146.38%
SMA50	145.35%
SMA200	228.18%
Trades

Shs Outstand	399.00M
Shs Float	365.28M
Short Float	13.62%
Short Ratio	7.26
Short Interest	49.77M
52W High	85.60 82.12%
52W Low	22.28 599.71%
Volatility	5.19% 5.79%
ATR (14)	10.56
RSI (14)	90.98
Beta	0.92
Rel Volume	27.32
Avg Volume	6.86M
Volume	154,930,518

Perf Week	144.85%
Perf Month	161.31%
Perf Quarter	240.98%
Perf Half Y	234.54%
Perf YTD	428.64%
Perf Year	458.56%
Perf 3Y	53.41%
Perf 5Y	-58.49%
Perf 10Y	-
Recom	2.85
Target Price	61.05
Prev Close	62.96
Price	155.90
Change %	147.61%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Upgrade	William Blair	Mkt Perform → Outperform
Today	Upgrade	BofA Securities	Underperform → Neutral
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90

Show Previous Ratings

Today 02:29PM	mRNA Vaccine Stocks Rise on Moderna-Merck Success (The Wall Street Journal) +147.61%
02:07PM	Moderna Could Be First S&P 500 Stock Since 2008 to Double in a Day (Barrons.com)
02:06PM	Merck Surges 7.5% After First Phase 3 mRNA Cancer-Vaccine Win (GuruFocus.com)
01:52PM	Moderna Shares Double After Cancer Vaccine Trial Delivers Major Win (GuruFocus.com)
01:49PM	TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial (Stocktwits)
01:37PM	Loading…
01:37PM	Gold Mining, Drug Stocks Breaking Out Today (Schaeffer's Research)
01:30PM	Amgen Stock Surges 3.5% as Healthcare Hits Record High (GuruFocus.com)
01:23PM	Moderna Stock Surges on Stunning Cancer Update (GuruFocus.com)
01:19PM	MSD and Moderna eye cancer vaccine market debut on Phase III melanoma score (Clinical Trials Arena)
12:54PM	Moderna Stock Doubles on Cancer Breakthrough: Heres What It Means (decrypt)
12:54PM	Moderna stock surges as melanoma vaccine trial shows "landmark moment" (CBS News)
12:53PM	Moderna and Merck Revive mRNA Hopes With Melanoma Success (Bloomberg)
12:43PM	Wall St recovers as yields ease; Moderna lifts healthcare stocks (Reuters)
12:13PM	From COVID to Cancer: Moderna Scores Melanoma Breakthrough (Zacks)
12:00PM	Flash Heard: Why Healthcare Is Partying Like It's Late 2020 (The Wall Street Journal)
11:51AM	Loading…
11:51AM	Moderna short sellers face $4.8 billion loss amid record stock jump (Investing.com)
11:48AM	Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings \| Stock Movers (Bloomberg)
11:41AM	Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test (Associated Press)
11:16AM	Healthcare stocks emerge as market's standout after Moderna and Merck's cancer breakthrough (MarketWatch)
11:15AM	Moderna, Merck cancer vaccine shows promise in late-stage trial (CNBC TV)
10:46AM	Moderna Stock Jumps 86% on First mRNA Cancer Trial Win (GuruFocus.com)
10:43AM	Moderna & Merck stocks skyrocket on their cancer vaccine trial's success. Here's what to know. (Yahoo Finance Video)
10:38AM	Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trial (Proactive)
10:34AM	Earnings, Cancer Vaccine, Long-Term Liquidity: A Busy Pre-Market (Zacks)
10:16AM	Moderna Stock Eyes Best Day Ever After Cancer Vaccine Breakthrough (Schaeffer's Research)
10:14AM	Tech sell-off resumes, counterbalancing bond yield relief: AlphaCheck (Yahoo Finance)
10:09AM	Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough (BeInCrypto)
09:39AM	Dow rises 230 points after Treasury doubles bond buybacks (Quartz)
09:38AM	Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls (The Fly)
09:29AM	Moderna Shares Surge More Than 90% After Phase 3 Melanoma Trial Success (InvestorsHub)
08:28AM	Loading…
08:28AM	Moderna stock is soaring in premarket after encouraging trial of cancer vaccine (MarketWatch)
08:15AM	Moderna's stock doubles on promising cancer-vaccine results (MarketWatch)
08:11AM	MRNA Stock Heads For Its Best Ever Day After Melanoma Therapy Meets Primary Goal (Stocktwits)
07:59AM	Premarket movers: Moderna jumps after Phase 3 trial; Target slides (Investing.com)
07:40AM	Moderna Skyrockets Over 60%, Merck Jumps On Late-Stage Cancer Vaccine Trial Win (Investor's Business Daily)
07:40AM	Moderna and Merck's personalized skin cancer vaccine cleared its first large-scale trial (Quartz)
07:38AM	Moderna's Cancer Breakthrough Just Sent the Stock Soaring (Barrons.com)
07:37AM	Moderna shares soar 60% on melanoma vaccine trial success (Financial Times)
07:35AM	Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market (Barrons.com)
07:17AM	Moderna, Merck Stock Jumps on Melanoma Vaccine News (The Wall Street Journal)
06:45AM	Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma (Business Wire)
06:45AM	At Last, a Successful Cancer Vaccine from Merck and Moderna (Barrons.com)
Aug-17-26 02:54PM	Behind the Ticker: How VFLO Beats Growth at Its Own Game (etf.com)
05:11AM	FDA nod is just the first hurdle for Modernas potential blockbuster flu vax (Pharma Voice)
Aug-10-26 12:01PM	FDA approval of mFLUSIVA highlights Modernas position in mRNA market (Clinical Trials Arena)
11:16AM	RocketLab Rises on Space Interest; Moderna Moves on Flu Shot \| Stock Movers (Bloomberg)
Aug-07-26 08:30AM	Roivant Sciences Ltd. Q1 2026 Earnings Call Summary (Moby) +9.86%
12:01AM	For Modernas Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off (The Daily Upside)
Aug-06-26 04:14PM	Moderna Dives Despite Hard-Fought FDA Win; Will Its Sprint Restart? (Investor's Business Daily)
03:02PM	Roivant Sciences Ltd (ROIV) (Q1 2026) Earnings Call Highlights: Strategic Advances and Strong ... (GuruFocus.com)
01:20PM	MRNA Stock Pares Gains Despite FDA Green Light For First mRNA Flu Vaccine But Retail Cheers Pivot Beyond COVID (Stocktwits)
09:56AM	Moderna Stock Rises After mRNA Flu Shot Approval (The Wall Street Journal)
09:08AM	Moderna Stock Climbs on Flu Vaccine Approval (Schaeffer's Research)
08:26AM	Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future (Barrons.com)
08:23AM	5 Things to Know Before the Stock Market Opens on Thursday (Investopedia)
06:42AM	Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market (Barrons.com)
06:07AM	Moderna secures FDA approval for its first mRNA influenza vaccine (InvestorsHub)
Aug-05-26 10:15PM	Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA (ACCESSWIRE)
Aug-04-26 06:45PM	US Stock Futures Flat After S&P500, Dow End At Record Highs On Strong Earnings, Easing Geopolitical Concerns PLTR, AZN, CMG, MRNA In Focus (Stocktwits)
12:47PM	Moderna Doses First Participants In Ebola Vaccine Trial Ahead Of Key FDA Decision On Flu Shot (Stocktwits)
12:35PM	Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine (Barrons.com)
06:30AM	Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street? (Barrons.com)
Aug-03-26 05:26PM	MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus These FDA Decisions Could Shape August Trading (Stocktwits)
Jul-31-26 03:00PM	Moderna Inc (MRNA) (Q2 2026) Earnings Call Highlights: Revenue Beat and Pipeline Progress Amid ... (GuruFocus.com) -5.35%
10:40AM	Moderna beat earnings expectations but its norovirus vaccine trial hit a wall (Quartz)
10:30AM	Moderna Q2 earnings beat estimates as norovirus vaccine stumbles (Quartz)
07:45AM	Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations (The Wall Street Journal)
07:26AM	Moderna Earnings Are Better Than Expected So Why Is the Stock Falling? (Barrons.com)
07:06AM	Moderna: Q2 Earnings Snapshot (Associated Press)
07:00AM	Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates (ACCESSWIRE)
05:31AM	ExxonMobil and other companies set to report earnings (MarketWatch)
Jul-30-26 11:45AM	When will fusion power startup Commonwealth Fusion Systems go public? (TechCrunch) +6.29%
Jul-24-26 08:30PM	FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions (Stocktwits) -5.17%
Jul-23-26 11:01AM	Dassault Systemes SE (DASTF) (H1 2026) Earnings Call Highlights: Strong Subscription Growth and ... (GuruFocus.com)
11:00AM	Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company? (Trefis)
Jul-17-26 07:44AM	Neglected Quant Safety Trade Makes a Comeback as AI Risks Rise (Bloomberg)
06:07AM	Arbutus, Sanofi escalate mRNA patent fights; InnoCares TYK2 contender advances (BioPharma Dive)
Jul-16-26 02:41PM	ABUS Stock On Track For Best Day In About Two Months Whats The Moderna Connection? (Stocktwits) -7.51%
Jul-14-26 01:35PM	Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies (Proactive)
Jul-13-26 09:12AM	What It Means To Hold Moderna Stock In A Crash (Trefis)
04:20AM	Moderna, Takeda and Capricor on the verge of notching big drug approvals (Pharma Voice)
Jul-10-26 05:07PM	Stock Market Today: Dow Ends Higher; SK Hynix Jumps In U.S. Trading Debut; Moderna Tumbles (Investor's Business Daily) -10.83%
03:37PM	MRNA Stock Eyes Worst Week In 11 Months After June Surge Whats Ahead? (Stocktwits)
Jul-09-26 01:11PM	Moderna secures up to 24 million RSV vaccine dose contract with Europe (Pharmaceutical Technology)
07:00AM	Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026 (ACCESSWIRE)
Jul-08-26 01:36PM	Momentum ETFs Are Actually Holding Up (Barrons.com) -7.48%
08:12AM	Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over' (Proactive)
07:00AM	Moderna Appoints Michael McDonnell to Board of Directors (ACCESSWIRE)
Jul-07-26 02:28PM	ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week (Stocktwits)
Jul-02-26 12:18AM	Why Did PANW, AAL, MRNA Surge To 52-Week Highs? (Stocktwits) +10.01%
Jun-30-26 05:13PM	The 20 best-performing stocks in the S&P 500 for the first half of 2026 (MarketWatch)
Jun-29-26 04:12PM	Stocks Rally to Start a Big Holiday Week: Stock Market Today (Kiplinger)
03:25AM	This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date (BeInCrypto)
01:55AM	MRNA Stock Rallies Over 40% In June: Moderna Bets Its Future On Cancer, Autoimmune Disease And AI-Powered mRNA (Stocktwits)
Jun-28-26 11:56PM	Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
Jun-26-26 06:05PM	S&P 500 ends lower; chips tumble and Moderna rallies (Reuters Videos) +12.59%
04:11PM	Stocks Struggle After OpenAI IPO Blow: Stock Market Today (Kiplinger)
03:54PM	Trending: Netflix stock bounces back, Moderna surges postinvestor day, ON Semi plummets (Yahoo Finance Video)
02:39PM	Healthcare stocks have become a haven for investors ditching tech (MarketWatch)
02:29PM	Moderna Shares Up on New Research Efforts for Autoimmune Disorder (The Wall Street Journal)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Technical Operations & Quality OfficerDr. Jerh Collins Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Option Exercise	19.15	499,246	9,560,561	6,687,037	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 06 '26	Option Exercise	19.15	252,469	4,834,781	6,440,260	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Sale	57.52	499,246	28,715,011	6,187,791	Aug 07 04:11 PM
Bancel Stephane	Officer	Aug 05 '26	Proposed Sale	58.00	499,246	28,956,268		Aug 05 01:02 PM
Hoge Stephen	President	Jul 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jul 16 04:45 PM
Hoge Stephen	President	Jul 15 '26	Sale	67.60	53,336	3,605,514	1,483,848	Jul 16 04:45 PM
Hoge Stephen	Officer	Jul 15 '26	Proposed Sale	67.60	53,336	3,605,514		Jul 15 10:22 AM
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your Finviz experience